This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Purification and initial characterization of Plasmodium falciparum K+ channels, PfKch1 and PfKch2 produced in Saccharomyces cerevisiae
Microbial Cell Factories Open Access 21 September 2020
-
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
Malaria Journal Open Access 20 March 2018
-
SC83288 is a clinical development candidate for the treatment of severe malaria
Nature Communications Open Access 31 January 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
13 January 2016
In the version of this article initially published, the position of the mutation reported in ref. 7 was incorrectly described as L236; it should be L263. In addition, in the HTML version of this article originally published, the concentration of artemisinin was given incorrectly as 50 mM instead of 50 μM; the PDF version and the legend text were correct. The errors have been corrected in the PDF and HTML versions of the article.
References
Eckstein-Ludwig, U. et al. Nature 424, 957–961 (2003).
Uhlemann, A.C. et al. Nat. Struct. Mol. Biol. 12, 628–629 (2005).
Cardi, D. et al. J. Biol. Chem. 285, 26406–26416 (2010).
Ariey, F. et al. Nature 505, 50–55 (2014).
Phompradit, P., Wisedpanichkij, R., Muhamad, P., Chaijaroenkul, W. & Na-Bangchang, K. Acta Trop. 120, 130–135 (2011).
Jambou, R. et al. PLoS One 5, e9424 (2010).
Chilongola, J., et al. Malar. Res. Treat. 2015, 279028 (2015).
Valderramos, S.G., Scanfeld, D., Uhlemann, A.-C., Fidock, D.A. & Krishna, S. Antimicrob. Agents Chemother. 54, 3842–3852 (2010).
Krishna, S., Pulcini, S., Fatih, F. & Staines, H. Trends Parasitol. 26, 517–523 (2010).
Uhlemann, A.C. et al. Nat. Struct. Mol. Biol. 19, 264 (2012).
Krishna, S., Pulcini, S., Moore, C.M., Teo, B.H. & Staines, H.M. Trends Pharmacol. Sci. 35, 4–11 (2014).
Arnou, B. et al. Biochem. Soc. Trans. 39, 823–831 (2011).
David-Bosne, S. et al. FEBS J. 280, 5419–5429 (2013).
Krishna, S. et al. J. Biol. Chem. 276, 10782–10787 (2001).
Spillman, N.J. et al. Cell Host Microbe 13, 227–237 (2013).
Rottmann, M. et al. Science 329, 1175–1180 (2010).
Ghorbal, M. et al. Nat. Biotechnol. 32, 819–821 (2014).
Straimer, J. et al. Science 347, 428–431 (2014).
Mok, S. et al. Science 347, 431–435 (2015).
Miotto, O. et al. Nat. Genet. 47, 226–234 (2015).
Tun, K.M. et al. Lancet Infect. Dis. 15, 415–421 (2015).
Mbengue, A. et al. Nature 520, 683–687 (2015).
Dogovski, C. et al. PLoS Biol. 13, e1002132 (2015).
Acknowledgements
The authors are very grateful to C. Jaxel (UMR 9198, Gif sur Yvette) for invaluable help throughout this study; to I. Florent (UMR 7245, Paris) for the direct test of artemisinin on live parasites; to C. Montigny (UMR 9198, Gif sur Yvette) for complementary experiments and fruitful discussions; to D. Cardi (UMR 9198, Gif sur Yvette), who initiated the work on PfATP6; to B. Arnou (Aarhus University) for preliminary work on the oocyte system; to B. Gasnier and C. Jouffret (UMR 8192, Paris) for the gift of control oocytes; to B. Miroux (UMR 7099, Paris) for continuous support; and to G. Lenoir, P. Champeil and J.L. Vazquez-Ibar (UMR 9198, Gif sur Yvette) for fruitful discussions.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4 and Supplementary Note (PDF 353 kb)
Rights and permissions
About this article
Cite this article
David-Bosne, S., Clausen, M., Poulsen, H. et al. Reappraising the effects of artemisinin on the ATPase activity of PfATP6 and SERCA1a E255L expressed in Xenopus laevis oocytes. Nat Struct Mol Biol 23, 1–2 (2016). https://doi.org/10.1038/nsmb.3156
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.3156
This article is cited by
-
Purification and initial characterization of Plasmodium falciparum K+ channels, PfKch1 and PfKch2 produced in Saccharomyces cerevisiae
Microbial Cell Factories (2020)
-
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
Malaria Journal (2018)
-
SC83288 is a clinical development candidate for the treatment of severe malaria
Nature Communications (2017)
-
Erratum: Reappraising the effects of artemisinin on the ATPase activity of PfATP6 and SERCA1a E255L expressed in Xenopus laevis oocytes
Nature Structural & Molecular Biology (2016)